231 related articles for article (PubMed ID: 32107212)
21. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
Yoo HY; Sung MK; Lee SH; Kim S; Lee H; Park S; Kim SC; Lee B; Rho K; Lee JE; Cho KH; Kim W; Ju H; Kim J; Kim SJ; Kim WS; Lee S; Ko YH
Nat Genet; 2014 Apr; 46(4):371-5. PubMed ID: 24584070
[TBL] [Abstract][Full Text] [Related]
22. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2015 Mar; 56(3):246-52. PubMed ID: 25876776
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.
Magni M; Biancon G; Rizzitano S; Cavanè A; Paolizzi C; Dugo M; Corradini P; Carniti C
Br J Cancer; 2019 Oct; 121(7):567-577. PubMed ID: 31474759
[TBL] [Abstract][Full Text] [Related]
24. Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for
Hsu YT; Wang YC; Chen RY; Hung LY; Li SS; Yen CC; Chen TY; Medeiros LJ; Chang KC
Leuk Lymphoma; 2020 May; 61(5):1108-1118. PubMed ID: 31870198
[TBL] [Abstract][Full Text] [Related]
25. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
[TBL] [Abstract][Full Text] [Related]
26. [Angioimmunoblastic T-cell lymphoma: histopathological grading and prognosis].
Guo YM; Liu XF; Jiao LJ; Yin SY; Wang Z; Li XX; Ma ZP; Yang JM; He MX
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):784-790. PubMed ID: 31594043
[No Abstract] [Full Text] [Related]
27. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.
Nagao R; Kikuti YY; Carreras J; Kikuchi T; Miyaoka M; Matsushita H; Kojima M; Ando K; Sakata-Yanagimoto M; Chiba S; Nakamura N
Am J Surg Pathol; 2016 Aug; 40(8):1041-50. PubMed ID: 27158755
[TBL] [Abstract][Full Text] [Related]
29. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
[TBL] [Abstract][Full Text] [Related]
30. Clonal germinal center B cells function as a niche for T-cell lymphoma.
Fujisawa M; Nguyen TB; Abe Y; Suehara Y; Fukumoto K; Suma S; Makishima K; Kaneko C; Nguyen YTM; Usuki K; Narita K; Matsue K; Nakamura N; Ishikawa S; Miura F; Ito T; Suzuki A; Suzuki Y; Mizuno S; Takahashi S; Chiba S; Sakata-Yanagimoto M
Blood; 2022 Nov; 140(18):1937-1950. PubMed ID: 35921527
[TBL] [Abstract][Full Text] [Related]
31. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
Fernandez-Pol S; Ma L; Joshi RP; Arber DA
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment.
Tari G; Lemonnier F; Morschhauser F
Curr Opin Oncol; 2021 Sep; 33(5):400-405. PubMed ID: 34230442
[TBL] [Abstract][Full Text] [Related]
33. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
[TBL] [Abstract][Full Text] [Related]
34. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
[TBL] [Abstract][Full Text] [Related]
35. Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis.
Zang S; Li J; Yang H; Zeng H; Han W; Zhang J; Lee M; Moczygemba M; Isgandarova S; Yang Y; Zhou Y; Rao A; You MJ; Sun D; Huang Y
J Clin Invest; 2017 Aug; 127(8):2998-3012. PubMed ID: 28691928
[TBL] [Abstract][Full Text] [Related]
36. GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.
Mondragón L; Mhaidly R; De Donatis GM; Tosolini M; Dao P; Martin AR; Pons C; Chiche J; Jacquin M; Imbert V; Proïcs E; Boyer L; Doye A; Luciano F; Neels JG; Coutant F; Fabien N; Sormani L; Rubio-Patiño C; Bossowski JP; Muller F; Marchetti S; Villa E; Peyron JF; Gaulard P; Lemonnier F; Asnafi V; Genestier L; Benhida R; Fournié JJ; Passeron T; Ricci JE; Verhoeyen E
Cancer Cell; 2019 Sep; 36(3):268-287.e10. PubMed ID: 31447347
[TBL] [Abstract][Full Text] [Related]
37. Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.
Lemonnier F; Mak TW
J Pathol; 2017 Aug; 242(4):387-390. PubMed ID: 28543514
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.
Cheminant M; Bruneau J; Kosmider O; Lefrere F; Delarue R; Gaulard P; Radford I; Derrieux C; Hermine O; Lemonnier F
Br J Haematol; 2015 Mar; 168(6):913-6. PubMed ID: 25312805
[No Abstract] [Full Text] [Related]
39. DNMT3A
Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
[TBL] [Abstract][Full Text] [Related]
40. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
